PT2268292T - Métodos e composições para o tratamento de cancro - Google Patents

Métodos e composições para o tratamento de cancro

Info

Publication number: PT2268292T
Authority: PT; Portugal
Prior art keywords: cancer; compositions; treatment
Prior art date: 2008-03-27

Application number

PT97237887T

Other languages

English (en)

Inventor

Burger Angelika

Hendriks Hans

Rademaker Bernardus

Original Assignee

Kominox Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-27

Filing date

2009-03-24

Publication date

2018-02-19

2009-03-24 Application filed by Kominox Inc filed Critical Kominox Inc

2018-02-19 Publication of PT2268292T publication Critical patent/PT2268292T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT97237887T 2008-03-27 2009-03-24 Métodos e composições para o tratamento de cancro PT2268292T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3998708P	2008-03-27	2008-03-27
US12/408,864 US20090246291A1 (en)	2008-03-27	2009-03-23	Method and compositions for treatment of cancer

Publications (1)

Publication Number	Publication Date
PT2268292T true PT2268292T (pt)	2018-02-19

Family

ID=41114644

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT97237887T PT2268292T (pt)	2008-03-27	2009-03-24	Métodos e composições para o tratamento de cancro

Country Status (20)

Country	Link
US (2)	US20090246291A1 (pt)
EP (1)	EP2268292B1 (pt)
JP (2)	JP5543956B2 (pt)
KR (1)	KR101634138B1 (pt)
CN (2)	CN104997808A (pt)
AU (1)	AU2009228378B2 (pt)
BR (1)	BRPI0909164A2 (pt)
CA (1)	CA2719766C (pt)
CY (1)	CY1120536T1 (pt)
DK (1)	DK2268292T3 (pt)
ES (1)	ES2656762T3 (pt)
HU (1)	HUE036609T2 (pt)
LT (1)	LT2268292T (pt)
MX (1)	MX2010010621A (pt)
PL (1)	PL2268292T3 (pt)
PT (1)	PT2268292T (pt)
RU (1)	RU2508116C2 (pt)
SI (1)	SI2268292T1 (pt)
WO (1)	WO2009120697A2 (pt)
ZA (1)	ZA201006988B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1721615A1 (en)	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en)	2010-03-01	2016-09-20	University Of Tennessee Research Foundation	Compounds for treatment of cancer
SG179069A1 (en) *	2009-09-10	2012-04-27	Kominox Inc	Cancer stem cell-targeted and drug resistant cancer therapy
US8795738B2 (en) *	2009-11-12	2014-08-05	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection
US11084811B2 (en)	2010-03-01	2021-08-10	Oncternal Therapeutics, Inc.	Compounds for treatment of cancer
CN103153303A (zh) *	2010-07-18	2013-06-12	尼基制药公司	使用钌络合物的联合疗法
MX336761B (es) *	2010-08-24	2016-01-29	Univ Tennessee Res Foundation	Compuestos para el tratamiento de cancer.
WO2012131487A2 (en) *	2011-03-30	2012-10-04	Kominox, Inc.	Compositions and methods for the treatment of cancer
US8834938B2 (en)	2011-05-18	2014-09-16	Board Of Regents Of The University Of Texas System	Use of arsenic for cancer therapy protection
EP2707008A4 (en) *	2011-05-12	2014-11-26	Univ Texas	USE OF ARSEN FOR CANCER THERAPY PROTECTION
US20160184356A1 (en) *	2013-03-15	2016-06-30	Ke Jian Jim Liu	Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko)	2013-03-15	2013-09-23	박상채	항암 활성 증진용 한약재 및 이의 제조방법
US20160166632A1 (en) *	2013-07-19	2016-06-16	Onyx Therapeutics, Inc.	Peptide epoxyketone proteasome inhibitors in combination with pim kinase inhibitors for treatment of cancers
CA3041357A1 (en)	2016-12-01	2018-06-07	Eupharma Pty Ltd	Diarsenic tetraoxide compositions and their use in the treatment of cancers
KR102868121B1 (ko)	2018-03-22	2025-10-14	코미팜 인터내셔널 오스트레일리아 피티와이 엘티디	메타 아비산염을 포함하는 약학 조성물 및 제조 방법
CN116236505A (zh) *	2023-03-15	2023-06-09	上海市第四人民医院	三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2018858T3 (da) *	1997-10-15	2013-01-07	Polarx Biopharmaceuticals Inc	Sammensætninger og fremgangsmåder til behandlingen af primære og metastatiske neoplastiske sygdomme ved anvendelse af arsentrioxid
BR9814857A (pt) *	1997-11-10	2001-12-26	Sloan Kettering Inst Cancer	Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
KR20020083678A (ko) *	2001-04-28	2002-11-04	주식회사 한국미생물연구소	아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
NZ536452A (en) *	2002-04-10	2007-06-29	Komipharm Internat Co	Use of sodium meta-arsenite (AsO2-) for manufacture of a pharmaceutical composition for the treatment of a solid malignancy
EP1721615A1 (en)	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) *	2005-08-23	2012-01-17	Stc.Unm	Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
US7867492B2 (en) *	2007-10-12	2011-01-11	The John Hopkins University	Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

2009
- 2009-03-23 US US12/408,864 patent/US20090246291A1/en not_active Abandoned
- 2009-03-24 DK DK09723788.7T patent/DK2268292T3/en active
- 2009-03-24 BR BRPI0909164A patent/BRPI0909164A2/pt not_active Application Discontinuation
- 2009-03-24 WO PCT/US2009/038104 patent/WO2009120697A2/en not_active Ceased
- 2009-03-24 EP EP09723788.7A patent/EP2268292B1/en active Active
- 2009-03-24 PL PL09723788T patent/PL2268292T3/pl unknown
- 2009-03-24 CA CA2719766A patent/CA2719766C/en active Active
- 2009-03-24 RU RU2010143893/15A patent/RU2508116C2/ru active
- 2009-03-24 CN CN201510355863.5A patent/CN104997808A/zh active Pending
- 2009-03-24 LT LTEP09723788.7T patent/LT2268292T/lt unknown
- 2009-03-24 PT PT97237887T patent/PT2268292T/pt unknown
- 2009-03-24 CN CN2009801187686A patent/CN102046187A/zh active Pending
- 2009-03-24 KR KR1020107024132A patent/KR101634138B1/ko active Active
- 2009-03-24 MX MX2010010621A patent/MX2010010621A/es active IP Right Grant
- 2009-03-24 ES ES09723788.7T patent/ES2656762T3/es active Active
- 2009-03-24 JP JP2011501983A patent/JP5543956B2/ja not_active Expired - Fee Related
- 2009-03-24 AU AU2009228378A patent/AU2009228378B2/en not_active Ceased
- 2009-03-24 SI SI200931809T patent/SI2268292T1/en unknown
- 2009-03-24 HU HUE09723788A patent/HUE036609T2/hu unknown
2010
- 2010-09-30 ZA ZA2010/06988A patent/ZA201006988B/en unknown
2014
- 2014-03-10 JP JP2014046212A patent/JP2014101387A/ja not_active Withdrawn
2017
- 2017-06-02 US US15/613,020 patent/US20180055812A1/en not_active Abandoned
2018
- 2018-03-09 CY CY20181100285T patent/CY1120536T1/el unknown

Also Published As

Publication number	Publication date
SI2268292T1 (en)	2018-03-30
BRPI0909164A2 (pt)	2016-06-21
CA2719766C (en)	2017-10-31
EP2268292A4 (en)	2011-05-11
KR101634138B1 (ko)	2016-06-28
RU2508116C2 (ru)	2014-02-27
US20180055812A1 (en)	2018-03-01
CY1120536T1 (el)	2019-07-10
LT2268292T (lt)	2018-03-26
KR20110009664A (ko)	2011-01-28
CA2719766A1 (en)	2009-10-01
DK2268292T3 (en)	2018-03-12
AU2009228378B2 (en)	2014-07-17
WO2009120697A2 (en)	2009-10-01
MX2010010621A (es)	2011-04-05
AU2009228378A1 (en)	2009-10-01
ES2656762T3 (es)	2018-02-28
CN104997808A (zh)	2015-10-28
PL2268292T3 (pl)	2018-06-29
WO2009120697A3 (en)	2010-02-18
EP2268292A2 (en)	2011-01-05
RU2010143893A (ru)	2012-05-10
EP2268292B1 (en)	2017-12-27
WO2009120697A4 (en)	2010-04-15
CN102046187A (zh)	2011-05-04
JP2014101387A (ja)	2014-06-05
ZA201006988B (en)	2012-05-30
US20090246291A1 (en)	2009-10-01
JP2011515481A (ja)	2011-05-19
HUE036609T2 (hu)	2018-07-30
JP5543956B2 (ja)	2014-07-09

Publication	Publication Date	Title
ZA201006988B (en)	2012-05-30	Method and compositions for treatment of cancer
IL267342A (en)	2019-08-29	Antibodies and preparations containing them for the treatment of cancer
IL218987A0 (en)	2012-06-28	Methods and compositions for treating cancer
PL2340042T3 (pl)	2015-01-30	Sposoby i kompozycje do leczenia raka
PL2200431T3 (pl)	2017-01-31	Nowe kompozycje i metody służące leczeniu raka
SG10201510152RA (en)	2016-01-28	Diagnostic methods and compositions for treatment of cancer
IL214255A0 (en)	2011-09-27	Methods and compositions for diagnosis and treatment of cancer
HUE062354T2 (hu)	2023-10-28	Módosított humán arginázokat tartalmazó készítmények és eljárások rák kezelésére
EP2429584A4 (en)	2013-02-20	TREATMENT PROCEDURE AND COMPOSITIONS
IL214349A0 (en)	2011-09-27	Compositions and methods for the treatment of cancer
IL199689A0 (en)	2010-04-15	Compounds and method for treatment of cancer
EP2176406A4 (en)	2011-10-19	COMPOSITIONS AND METHOD FOR CANCER TREATMENT
EP2225226A4 (en)	2012-03-14	COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2515652A4 (en)	2014-11-26	COMPOSITIONS AND METHODS FOR TREATING VITILIGO
IL196727A0 (en)	2011-08-01	Composition and method for treatment of tumors
GB0808326D0 (en)	2008-06-18	Compositions and methods for the treatment of fybromyalgia
HUE054409T2 (hu)	2021-09-28	Új kompozíciók és eljárások rák kezelésére